Kinagif 250 Tablet
Marketer
Zeelab Pharmacy Pvt Ltd
Salt Composition
Gefitinib (250mg)
Overview Kinagif 250 Tablet
Afatinib 250mg tablets treat metastatic non-small cell lung cancer in previously untreated patients with abnormal epidermal growth factor receptor (EGFR) gene mutations. Dosage should strictly follow your physician's instructions, continuing treatment for the prescribed duration, which depends on individual response. Regular liver function monitoring may be advised. Common side effects include nausea, diarrhea, dry skin, and appetite loss. Increased fluid intake may help mitigate side effects. Report any concerning or worsening side effects, particularly mouth sores, vision changes, or breathing problems. Women should utilize reliable contraception throughout treatment and for one month post-treatment to prevent pregnancy. Disclose all other medications you are currently using to your doctor.
Uses of Kinagif 250 Tablet
Lung cancer (excluding small cell type)
Major Benefits of Kinagif 250 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Kinagif 250 Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Kinagif 250 Tablet:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reaction
How to use Kinagif 250 Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Kinagif 250 Tablets can be consumed with or without food, though consistent timing is recommended.
How Kinagif 250 Tablet works:
Kinagif 250 Tablets are an anti-neoplastic agent. Their mechanism of action involves inhibiting the activity of a faulty protein responsible for cancerous cell proliferation, thus curbing or retarding tumor growth.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Kinagif 250 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Kinagif 250 Tablet during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in potentially life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Kinagif 250 Tablet while breastfeeding is likely inadvisable. Available evidence from humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Kinagif 250 Tablet.
KidneyCAUTION
For individuals with advanced kidney impairment, Kinagif 250 Tablet requires careful administration. Dosage modification of Kinagif 250 Tablet may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Kinagif 250 Tablets appear to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary, though further data is limited. Physician consultation is recommended.
What if you forget to take Kinagif 250 Tablet :
Omit any missed Kinagif 250 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Kinagif 250 Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline amines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently